Artificial Intelligence and Early Detection of Pancreatic Cancer

Abstract Despite considerable research efforts, pancreatic cancer is associated with a dire prognosis and a 5-year survival rate of only 10%. Early symptoms of the disease are mostly nonspecific. The premise of improved survival through early detection is that more individuals will benefit from potentially curative treatment. Artificial intelligence (AI) methodology has emerged as a successful tool for risk stratification and identification in general health care. In response to the maturity of AI, Kenner Family Research Fund conducted the 2020 AI and Early Detection of Pancreatic Cancer Virtual Summit (www.pdac-virtualsummit.org) in conjunction with the American Pancreatic Association, with a focus on the potential of AI to advance early detection efforts in this disease. This comprehensive presummit article was prepared based on information provided by each of the interdisciplinary participants on one of the 5 following topics: Progress, Problems, and Prospects for Early Detection; AI and Machine Learning; AI and Pancreatic Cancer—Current Efforts; Collaborative Opportunities; and Moving Forward—Reflections from Government, Industry, and Advocacy. The outcome from the robust Summit conversations, to be presented in a future white paper, indicate that significant progress must be the result of strategic collaboration among investigators and institutions from multidisciplinary backgrounds, supported by committed funders.

[1]  Our world in data , 2022 .

[2]  M. Cabana,et al.  Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement. , 2021, JAMA.

[3]  Kevin Smith,et al.  Toward robust mammography-based models for breast cancer risk , 2021, Science Translational Medicine.

[4]  Yonina C. Eldar,et al.  Data-Driven Symbol Detection Via Model-Based Machine Learning , 2020, 2021 IEEE Statistical Signal Processing Workshop (SSP).

[5]  Yonina C. Eldar,et al.  Algorithm Unrolling: Interpretable, Efficient Deep Learning for Signal and Image Processing , 2019, IEEE Signal Processing Magazine.

[6]  C. Sander,et al.  CellBox: Interpretable Machine Learning for Perturbation Biology with Application to the Design of Cancer Combination Therapy. , 2020, Cell systems.

[7]  T. Behl,et al.  Early Diagnosis of Pancreatic Cancer: The Key for Survival , 2020, Diagnostics.

[8]  Jessica X Hjaltelin,et al.  Disease trajectory browser for exploring temporal, population-wide disease progression patterns in 7.2 million Danish patients , 2020, Nature Communications.

[9]  Regina Barzilay,et al.  Exploiting Rules to Enhance Machine Learning in Extracting Information From Multi-Institutional Prostate Pathology Reports. , 2020, JCO clinical cancer informatics.

[10]  S. Thakkar,et al.  Depression Before and After a Diagnosis of Pancreatic Cancer , 2020, Pancreas.

[11]  Amber L. Simpson,et al.  Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers , 2020, Cell.

[12]  N. Takahashi,et al.  Computerized tomography scan in pre-diagnostic pancreatic ductal adenocarcinoma: Stages of progression and potential benefits of early intervention: A retrospective study. , 2020, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[13]  R. Scragg,et al.  Exocrine Pancreatic Dysfunction Increases the Risk of New‐Onset Diabetes Mellitus: Results of a Nationwide Cohort Study , 2020, Clinical and translational science.

[14]  Laney K. Jones,et al.  Clinical outcomes of a genomic screening program for actionable genetic conditions , 2020, Genetics in Medicine.

[15]  S. Hanash,et al.  Biomarkers and Strategy to Detect Preinvasive and Early Pancreatic Cancer: State of the Field and the Impact of the EDRN , 2020, Cancer Epidemiology, Biomarkers & Prevention.

[16]  E. Vassos,et al.  Polygenic risk scores: from research tools to clinical instruments , 2020, Genome Medicine.

[17]  T. Kadir,et al.  Assessing the Accuracy of a Deep Learning Method to Risk Stratify Indeterminate Pulmonary Nodules , 2020, American journal of respiratory and critical care medicine.

[18]  T. Evgeniou,et al.  The need for a system view to regulate artificial intelligence/machine learning-based software as medical device , 2020, npj Digital Medicine.

[19]  Bechien U. Wu,et al.  Identification of Individuals at Increased Risk for Pancreatic Cancer in a Community-Based Cohort of Patients With Suspected Chronic Pancreatitis , 2020, Clinical and translational gastroenterology.

[20]  Søren Brunak,et al.  Dynamic and explainable machine learning prediction of mortality in patients in the intensive care unit: a retrospective study of high-frequency data in electronic patient records. , 2020, The Lancet. Digital health.

[21]  P. Storz,et al.  Carcinogenesis of Pancreatic Ductal Adenocarcinoma. , 2020, Gastroenterology.

[22]  T. Rohan,et al.  Diabetes, Glycated Hemoglobin, and Risk of Cancer in the UK Biobank Study , 2020, Cancer Epidemiology, Biomarkers & Prevention.

[23]  Andrew M. Dai,et al.  Predicting Inpatient Medication Orders From Electronic Health Record Data , 2020, Clinical pharmacology and therapeutics.

[24]  Rob Knight,et al.  Microbiome analyses of blood and tissues suggest cancer diagnostic approach , 2020, Nature.

[25]  Bechien U. Wu,et al.  Prediction of Pancreatic Cancer Based on Imaging Features in Patients With Duct Abnormalities , 2020, Pancreas.

[26]  S. Lo,et al.  Multiparametric Mapping Magnetic Resonance Imaging of Pancreatic Disease , 2020, Frontiers in Physiology.

[27]  Emma J. Chory,et al.  A Deep Learning Approach to Antibiotic Discovery , 2020, Cell.

[28]  L. Buscail,et al.  Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer , 2020, Nature Reviews Gastroenterology & Hepatology.

[29]  S. Lo,et al.  Six‐dimensional quantitative DCE MR Multitasking of the entire abdomen: Method and application to pancreatic ductal adenocarcinoma , 2020, Magnetic resonance in medicine.

[30]  R. Hruban,et al.  Recent trends in the incidence and survival of Stage 1A Pancreatic Cancer: A Surveillance, Epidemiology, and End Results analysis. , 2020, Journal of the National Cancer Institute.

[31]  David T. Jones,et al.  Improved protein structure prediction using potentials from deep learning , 2020, Nature.

[32]  A. Jemal,et al.  Cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.

[33]  Chris Sander,et al.  Pathway Commons 2019 Update: integration, analysis and exploration of pathway data , 2019, Nucleic Acids Res..

[34]  Yonina C. Eldar,et al.  Deep Learning in Ultrasound Imaging , 2019, Proceedings of the IEEE.

[35]  Dhruv R. Seshadri,et al.  Accuracy of the Apple Watch 4 to Measure Heart Rate in Patients With Atrial Fibrillation , 2020, IEEE Journal of Translational Engineering in Health and Medicine.

[36]  S. Duffy,et al.  Development of PancRISK, a urine biomarker-based risk score for stratified screening of pancreatic cancer patients , 2019, British Journal of Cancer.

[37]  Kevin Smith,et al.  Comparison of a Deep Learning Risk Score and Standard Mammographic Density Score for Breast Cancer Risk Prediction. , 2019, Radiology.

[38]  Bechien U. Wu,et al.  New-onset Diabetes, Longitudinal Trends in Metabolic Markers, and Risk of Pancreatic Cancer in a Heterogeneous Population. , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[39]  S. Joshua Swamidass,et al.  Precision Medicine in Pancreatic Disease—Knowledge Gaps and Research Opportunities , 2019, Pancreas.

[40]  Walter G. Park,et al.  Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium , 2019, Gut.

[41]  Mustafa Suleyman,et al.  Key challenges for delivering clinical impact with artificial intelligence , 2019, BMC Medicine.

[42]  Brian W. Powers,et al.  Dissecting racial bias in an algorithm used to manage the health of populations , 2019, Science.

[43]  Judy H. Cho,et al.  Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank , 2019, Genome Medicine.

[44]  M. van Meurs,et al.  Identifying Sepsis Phenotypes. , 2019, JAMA.

[45]  Yan Wang,et al.  Application of Deep Learning to Pancreatic Cancer Detection: Lessons Learned From Our Initial Experience. , 2019, Journal of the American College of Radiology : JACR.

[46]  K. Kinzler,et al.  Applications of liquid biopsies for cancer , 2019, Science Translational Medicine.

[47]  M. Cabana,et al.  Screening for Pancreatic Cancer: US Preventive Services Task Force Reaffirmation Recommendation Statement. , 2019, JAMA.

[48]  M. Stern,et al.  Differences in Pancreatic Cancer Incidence Rates and Temporal Trends Across Asian Subpopulations in California (1988-2015). , 2019, Pancreas.

[49]  Thomas J. Fuchs,et al.  Clinical-grade computational pathology using weakly supervised deep learning on whole slide images , 2019, Nature Medicine.

[50]  Bechien U. Wu,et al.  Do changes in health reveal the possibility of undiagnosed pancreatic cancer? Development of a risk-prediction model based on healthcare claims data , 2019, PloS one.

[51]  N. Keating,et al.  New Federal Requirements to Inform Patients About Breast Density: Will They Help Patients? , 2019, JAMA.

[52]  S. Brunak,et al.  Survival prediction in intensive-care units based on aggregation of long-term disease history and acute physiology: a retrospective study of the Danish National Patient Registry and electronic patient records. , 2019, The Lancet. Digital health.

[53]  H. Nielsen,et al.  Genome-wide cell-free DNA fragmentation in patients with cancer , 2019, Nature.

[54]  Aaron Roth,et al.  Average Individual Fairness: Algorithms, Generalization and Experiments , 2019, NeurIPS.

[55]  C. Haiman,et al.  Interethnic differences in pancreatic cancer incidence and risk factors: The Multiethnic Cohort , 2019, Cancer medicine.

[56]  R. Barzilay,et al.  A Deep Learning Mammography-based Model for Improved Breast Cancer Risk Prediction. , 2019, Radiology.

[57]  Eugene J Koay,et al.  Early Detection of Pancreatic Cancer: Opportunities and Challenges. , 2019, Gastroenterology.

[58]  A. Yuille,et al.  Utility of CT Radiomics Features in Differentiation of Pancreatic Ductal Adenocarcinoma From Normal Pancreatic Tissue. , 2019, AJR. American journal of roentgenology.

[59]  C. Langlotz,et al.  A Roadmap for Foundational Research on Artificial Intelligence in Medical Imaging: From the 2018 NIH/RSNA/ACR/The Academy Workshop. , 2019, Radiology.

[60]  M. Wallace,et al.  Cost-effectiveness of Pancreatic Cancer Surveillance in High-Risk Individuals: An Economic Analysis , 2019, Pancreas.

[61]  Regina Barzilay,et al.  Generative Models for Graph-Based Protein Design , 2019, DGS@ICLR.

[62]  R. Hruban,et al.  Deleterious Germline Mutations Are a Risk Factor for Neoplastic Progression Among High-Risk Individuals Undergoing Pancreatic Surveillance. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[63]  Søren Brunak,et al.  A Large-Cohort, Longitudinal Study Determines Precancer Disease Routes across Different Cancer Types. , 2019, Cancer research.

[64]  A. Khorana,et al.  Evaluating Susceptibility to Pancreatic Cancer: ASCO Clinical Practice Provisional Clinical Opinion Summary. , 2019, Journal of oncology practice.

[65]  S. Hanash,et al.  Exosomes harbor B cell targets in pancreatic adenocarcinoma and exert decoy function against complement-mediated cytotoxicity , 2019, Nature Communications.

[66]  Y. Liu,et al.  The sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy Over CA19-9 in Pancreatic Cancer Diagnosis , 2019, Clinical Cancer Research.

[67]  Eric J Topol,et al.  High-performance medicine: the convergence of human and artificial intelligence , 2019, Nature Medicine.

[68]  Andre Esteva,et al.  A guide to deep learning in healthcare , 2019, Nature Medicine.

[69]  Jennifer B Dennison,et al.  A Plasma-Derived Protein-Metabolite Multiplexed Panel for Early-Stage Pancreatic Cancer , 2018, Journal of the National Cancer Institute.

[70]  C. Haiman,et al.  Pancreatic Cancer Following Incident Diabetes in African Americans and Latinos: The Multiethnic Cohort , 2018, Journal of the National Cancer Institute.

[71]  Suresh Venkatasubramanian,et al.  A comparative study of fairness-enhancing interventions in machine learning , 2018, FAT.

[72]  Daniel C. Elton,et al.  Deep learning for molecular generation and optimization - a review of the state of the art , 2019, Molecular Systems Design & Engineering.

[73]  M. Howell,et al.  Ensuring Fairness in Machine Learning to Advance Health Equity , 2018, Annals of Internal Medicine.

[74]  Solon Barocas,et al.  Prediction-Based Decisions and Fairness: A Catalogue of Choices, Assumptions, and Definitions , 2018, 1811.07867.

[75]  Yonina C. Eldar,et al.  Deep Unfolded Robust PCA with Application to Clutter Suppression in Ultrasound , 2018, bioRxiv.

[76]  H. Steen,et al.  Standard Operating Procedures for Biospecimen Collection, Processing, and Storage: From the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer. , 2018, Pancreas.

[77]  Walter G. Park,et al.  A Prospective Study to Establish a New-Onset Diabetes Cohort: From the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer. , 2018, Pancreas.

[78]  M. Korc,et al.  Evaluation of a Mixed Meal Test for Diagnosis and Characterization of PancrEaTogEniC DiabeTes Secondary to Pancreatic Cancer and Chronic Pancreatitis: Rationale and Methodology for the DETECT Study From the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer. , 2018, Pancreas.

[79]  Ziding Feng,et al.  Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer: From Concept to Reality. , 2018, Pancreas.

[80]  D. Ahlquist Universal cancer screening: revolutionary, rational, and realizable , 2018, npj Precision Oncology.

[81]  Takahisa Kawaguchi,et al.  Prediction model for pancreatic cancer risk in the general Japanese population , 2018, PloS one.

[82]  Ziding Feng,et al.  Model to Determine Risk of Pancreatic Cancer in Patients With New-Onset Diabetes. , 2018, Gastroenterology.

[83]  E. Fishman,et al.  Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance. , 2018, Gastroenterology.

[84]  Pearse A. Keane,et al.  With an eye to AI and autonomous diagnosis , 2018, npj Digital Medicine.

[85]  M. Phipps,et al.  Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement , 2018, JAMA.

[86]  W. Hahn,et al.  Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer , 2018, Genetics in Medicine.

[87]  Le Lu,et al.  DeepLesion: automated mining of large-scale lesion annotations and universal lesion detection with deep learning , 2018, Journal of medical imaging.

[88]  Mary E. Haas,et al.  Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations , 2018, Nature Genetics.

[89]  Nicholas D. Camarda,et al.  Real-time Genomic Characterization of Advanced Pancreatic Cancer to Enable Precision Medicine. , 2018, Cancer discovery.

[90]  Ahmed Hosny,et al.  Artificial intelligence in radiology , 2018, Nature Reviews Cancer.

[91]  C. Hutter,et al.  The Cancer Genome Atlas: Creating Lasting Value beyond Its Data , 2018, Cell.

[92]  Steven J. M. Jones,et al.  Oncogenic Signaling Pathways in The Cancer Genome Atlas. , 2018, Cell.

[93]  Qi Yang,et al.  Magnetic resonance multitasking for motion-resolved quantitative cardiovascular imaging , 2018, Nature Biomedical Engineering.

[94]  John Langford,et al.  A Reductions Approach to Fair Classification , 2018, ICML.

[95]  Ludmila V. Danilova,et al.  Detection and localization of surgically resectable cancers with a multi-analyte blood test , 2018, Science.

[96]  Peter Kraft,et al.  Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer , 2018, Nature Communications.

[97]  Jeffrey Dean,et al.  Scalable and accurate deep learning with electronic health records , 2018, npj Digital Medicine.

[98]  M. Goggins,et al.  Pancreatic Juice Mutation Concentrations Can Help Predict the Grade of Dysplasia in Patients Undergoing Pancreatic Surveillance , 2018, Clinical Cancer Research.

[99]  J. Covington,et al.  Noninvasive Diagnosis of Pancreatic Cancer Through Detection of Volatile Organic Compounds in Urine. , 2017, Gastroenterology.

[100]  Ronald M. Summers,et al.  Spatial aggregation of holistically‐nested convolutional neural networks for automated pancreas localization and segmentation☆ , 2017, Medical Image Anal..

[101]  Henning Hermjakob,et al.  The Reactome pathway knowledgebase , 2013, Nucleic Acids Res..

[102]  K. Lillemoe,et al.  Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium , 2018, Annals of surgery.

[103]  S. Monaco,et al.  Preoperative next-generation sequencing of pancreatic cyst fluid is highly accurate in cyst classification and detection of advanced neoplasia , 2017, Gut.

[104]  M. Yurgelun Germline Testing for Individuals With Pancreatic Cancer: The Benefits and Challenges to Casting a Wider Net. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[105]  Masaya Suenaga,et al.  Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[106]  Lars Bolund,et al.  Sequencing and de novo assembly of 150 genomes from Denmark as a population reference , 2017, Nature.

[107]  B. Garcia,et al.  Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19-9 blood markers , 2017, Science Translational Medicine.

[108]  June-Goo Lee,et al.  Deep Learning in Medical Imaging: General Overview , 2017, Korean journal of radiology.

[109]  L. Andrews,et al.  Lost in translation: returning germline genetic results in genome-scale cancer research , 2017, Genome Medicine.

[110]  T. Ishizawa,et al.  Asymptomatic Pancreatic Cancer: Does Incidental Detection Impact Long-Term Outcomes? , 2017, Journal of Gastrointestinal Surgery.

[111]  S. Hanash,et al.  High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[112]  A. Rustgi,et al.  A Clinical Prediction Model to Assess Risk for Pancreatic Cancer Among Patients With New-Onset Diabetes. , 2017, Gastroenterology.

[113]  S. Yachida,et al.  The Prevalence and Clinicopathological Characteristics of High-Grade Pancreatic Intraepithelial Neoplasia: Autopsy Study Evaluating the Entire Pancreatic Parenchyma , 2017, Pancreas.

[114]  S. Chari,et al.  Early Detection of Pancreatic Cancer The Role of Industry in the Development of Biomarkers , 2017 .

[115]  Mithat Gönen,et al.  Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients With Pancreatic Adenocarcinoma , 2017, Annals of surgery.

[116]  F. Izzo,et al.  Multidetector computer tomography in the pancreatic adenocarcinoma assessment: an update , 2016, Infectious Agents and Cancer.

[117]  K. Kirkwood,et al.  Early and accurate diagnosis of pancreatic cancer? , 2016, Oncotarget.

[118]  M. Korc,et al.  Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer. , 2016, The lancet. Gastroenterology & hepatology.

[119]  Ziding Feng,et al.  Quantitative imaging to evaluate malignant potential of IPMNs , 2016, Oncotarget.

[120]  Sudhir Srivastava,et al.  Early Detection of Pancreatic Cancer—a Defined Future Using Lessons From Other Cancers , 2016, Pancreas.

[121]  S. Brunak,et al.  Network biology concepts in complex disease comorbidities , 2016, Nature Reviews Genetics.

[122]  C. Iacobuzio-Donahue,et al.  Pancreatic cancer biology and genetics from an evolutionary perspective , 2016, Nature Reviews Cancer.

[123]  R. Hruban,et al.  Digital next-generation sequencing identifies low-abundance mutations in pancreatic juice samples collected from the duodenum of patients with pancreatic cancer and intraductal papillary mucinous neoplasms , 2016, Gut.

[124]  M. Phipps,et al.  Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. , 2016, JAMA.

[125]  A. Carrato,et al.  Refinement of screening for familial pancreatic cancer , 2016, Gut.

[126]  R. Summers Progress in Fully Automated Abdominal CT Interpretation. , 2016, AJR. American journal of roentgenology.

[127]  K. Lillemoe,et al.  Recurrence and Survival After Resection of Small Intraductal Papillary Mucinous Neoplasm-associated Carcinomas (⩽20-mm Invasive Component): A Multi-institutional Analysis , 2016, Annals of surgery.

[128]  T. Wilt,et al.  Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement , 2011 .

[129]  H. Brenner,et al.  A systematic review of serum autoantibodies as biomarkers for pancreatic cancer detection , 2016, Oncotarget.

[130]  J. Mayerle,et al.  Pancreatic cancer in 2015: Precision medicine in pancreatic cancer — fact or fiction? , 2016, Nature Reviews Gastroenterology &Hepatology.

[131]  Susan M. Astley,et al.  Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort , 2015, Breast Cancer Research.

[132]  A. Krasinskas,et al.  A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas , 2015, The American journal of surgical pathology.

[133]  Jin-Young Jang,et al.  A combination of molecular markers and clinical features improve the classification of pancreatic cysts. , 2015, Gastroenterology.

[134]  Robert C. G. Martin,et al.  A cost analysis of a pancreatic cancer screening protocol in high-risk populations. , 2015, American journal of surgery.

[135]  J. Gohagan,et al.  The PLCO Biorepository: Creating, Maintaining, and Administering a Unique Biospecimen Resource. , 2015, Reviews on recent clinical trials.

[136]  Chris Sander,et al.  Perturbation biology nominates upstream–downstream drug combinations in RAF inhibitor resistant melanoma cells , 2015, eLife.

[137]  Christian Pilarsky,et al.  Glypican-1 identifies cancer exosomes and detects early pancreatic cancer , 2015, Nature.

[138]  R. Scharpf,et al.  Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients , 2015, Nature Communications.

[139]  Suresh T. Chari,et al.  Early Detection of Sporadic Pancreatic Cancer , 2015, Pancreas.

[140]  Geoffrey E. Hinton,et al.  Deep Learning , 2015, Nature.

[141]  D. Gouma,et al.  A multicentre comparative prospective blinded analysis of EUS and MRI for screening of pancreatic cancer in high-risk individuals , 2015, Gut.

[142]  A. Jemal,et al.  Prevalence of Major Risk Factors and Use of Screening Tests for Cancer in the United States , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[143]  J. Palmer,et al.  Prospective approach to breast cancer risk prediction in African American women: the black women's health study model. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[144]  J. Kench,et al.  Whole genomes redefine the mutational landscape of pancreatic cancer , 2015, Nature.

[145]  Robert P. Sheridan,et al.  Deep Neural Nets as a Method for Quantitative Structure-Activity Relationships , 2015, J. Chem. Inf. Model..

[146]  Randall W Burt,et al.  ACG Clinical Guideline: Genetic Testing and Management of Hereditary Gastrointestinal Cancer Syndromes , 2015, The American Journal of Gastroenterology.

[147]  Martin E. Fernandez-Zapico,et al.  Faculty Opinions recommendation of Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development. , 2015 .

[148]  S. Chari,et al.  Early Detection of Sporadic Pancreatic Cancer Strategic Map for Innovation — A White Paper , 2015 .

[149]  C. Schairer,et al.  Twenty-five Years of Breast Cancer Risk Models and Their Applications , 2015 .

[150]  M. Rickels,et al.  Total Pancreatectomy With Islet Autotransplantation: Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop , 2014, Pancreas.

[151]  Quoc V. Le,et al.  Sequence to Sequence Learning with Neural Networks , 2014, NIPS.

[152]  Gad Getz,et al.  Computational pathology: an emerging definition. , 2014, Archives of pathology & laboratory medicine.

[153]  W. Chung,et al.  BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high‐risk pancreatic cancer screening and pancreatic cancer cohorts , 2014, Cancer.

[154]  Tudor I. Oprea,et al.  Temporal disease trajectories condensed from population-wide registry data covering 6.2 million patients , 2014, Nature Communications.

[155]  R. Pai,et al.  Preoperative GNAS and KRAS Testing in the Diagnosis of Pancreatic Mucinous Cysts , 2014, Clinical Cancer Research.

[156]  Brendan J. Frey,et al.  Deep learning of the tissue-regulated splicing code , 2014, Bioinform..

[157]  Benjamin D. Smith,et al.  Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. , 2014, Cancer research.

[158]  D. Ransohoff,et al.  Multitarget stool DNA testing for colorectal-cancer screening. , 2014, The New England journal of medicine.

[159]  Daniel Levy,et al.  The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective , 2014, The Lancet.

[160]  M. Choti,et al.  Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies , 2014, Science Translational Medicine.

[161]  S. Chakraborty,et al.  Surgical resection improves survival in pancreatic cancer patients without vascular invasion- a population based study , 2013, Annals of gastroenterology.

[162]  D. Chia,et al.  Role of Pancreatic Cancer-derived Exosomes in Salivary Biomarker Development* , 2013, The Journal of Biological Chemistry.

[163]  Eftychia E. Kapsalaki,et al.  How reliable is MRCP with an SS-FSE sequence at 3.0 T: comparison between SS-FSE BH and 3D-FSE BH ASSET sequences. , 2013, Clinical imaging.

[164]  Dhiraj Yadav,et al.  The epidemiology of pancreatitis and pancreatic cancer. , 2013, Gastroenterology.

[165]  S. Chari,et al.  Prevalence of Diabetes Mellitus in Pancreatic Cancer Compared to Common Cancers , 2013, Pancreas.

[166]  Geoffrey E. Hinton,et al.  ImageNet classification with deep convolutional neural networks , 2012, Commun. ACM.

[167]  S. Das,et al.  Inherited pancreatic cancer syndromes. , 2012, Cancer journal.

[168]  Tara N. Sainath,et al.  Deep Neural Networks for Acoustic Modeling in Speech Recognition , 2012 .

[169]  Lincoln D. Stein,et al.  Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes , 2012, Nature.

[170]  Jeffrey E. Lee,et al.  Clinical calculator of conditional survival estimates for resected and unresected survivors of pancreatic cancer. , 2012, Archives of surgery.

[171]  D. Ahlquist,et al.  Stool DNA testing for the detection of pancreatic cancer , 2012, Cancer.

[172]  S. Brunak,et al.  Mining electronic health records: towards better research applications and clinical care , 2012, Nature Reviews Genetics.

[173]  Zhe Zhang,et al.  Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. , 2012, Gastroenterology.

[174]  A. Bordbar,et al.  Using the reconstructed genome‐scale human metabolic network to study physiology and pathology , 2012, Journal of internal medicine.

[175]  Thomas A. Hopf,et al.  Protein 3D Structure Computed from Evolutionary Sequence Variation , 2011, PloS one.

[176]  Jun Liu,et al.  Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies. , 2011, European journal of cancer.

[177]  C. Gatsonis,et al.  Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .

[178]  Mitchell H Gail,et al.  Projecting individualized absolute invasive breast cancer risk in Asian and Pacific Islander American women. , 2011, Journal of the National Cancer Institute.

[179]  D. Ahlquist,et al.  Stool DNA Testing for the Detection of Pancreatic Cancer: Identification and Assessment of Methylation Marker Candidates , 2011 .

[180]  Manuel Hidalgo,et al.  Convergent structural alterations define SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeler as a central tumor suppressive complex in pancreatic cancer , 2011, Proceedings of the National Academy of Sciences.

[181]  Gary D. Bader,et al.  Pathway Commons, a web resource for biological pathway data , 2010, Nucleic Acids Res..

[182]  Lincoln Stein,et al.  Reactome: a database of reactions, pathways and biological processes , 2010, Nucleic Acids Res..

[183]  M. Nowak,et al.  Distant Metastasis Occurs Late during the Genetic Evolution of Pancreatic Cancer , 2010, Nature.

[184]  Gary D Bader,et al.  BioPAX – A community standard for pathway data sharing , 2010, Nature Biotechnology.

[185]  Yann LeCun,et al.  Learning Fast Approximations of Sparse Coding , 2010, ICML.

[186]  Cancer Facts & Figures 2021 , 2010 .

[187]  A. Basu,et al.  New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. , 2009, The Lancet. Oncology.

[188]  W. Bamlet,et al.  Long-Term Survival and Prognostic Indicators in Small (≤2 cm) Pancreatic Cancer , 2008, Pancreatology.

[189]  G. Parmigiani,et al.  Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses , 2008, Science.

[190]  Ananda Basu,et al.  Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. , 2008, Gastroenterology.

[191]  Garnet L Anderson,et al.  The women's health initiative: lessons learned. , 2008, Annual review of public health.

[192]  Jean B. Cormack,et al.  Diagnostic accuracy of digital versus film mammography: exploratory analysis of selected population subgroups in DMIST. , 2008, Radiology.

[193]  Melissa Bondy,et al.  Projecting individualized absolute invasive breast cancer risk in African American women. , 2007, Journal of the National Cancer Institute.

[194]  S. Chari Detecting early pancreatic cancer: problems and prospects. , 2007, Seminars in oncology.

[195]  A. Siriwardena,et al.  Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer. , 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[196]  V. McCormack,et al.  Breast Density and Parenchymal Patterns as Markers of Breast Cancer Risk: A Meta-analysis , 2006, Cancer Epidemiology Biomarkers & Prevention.

[197]  M. Tatsuta,et al.  [Early detection of pancreatic cancer]. , 2006, Nihon rinsho. Japanese journal of clinical medicine.

[198]  Lucy Clayson Identifying sepsis. , 2006, Nursing Standard.

[199]  Mariza de Andrade,et al.  Probability of pancreatic cancer following diabetes: a population-based study. , 2005, Gastroenterology.

[200]  M. Woodward,et al.  Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies , 2005, British Journal of Cancer.

[201]  Michio Shimizu,et al.  An Illustrated Consensus on the Classification of Pancreatic Intraepithelial Neoplasia and Intraductal Papillary Mucinous Neoplasms , 2004, The American journal of surgical pathology.

[202]  Stephen W Duffy,et al.  A breast cancer prediction model incorporating familial and personal risk factors , 2004, Hereditary Cancer in Clinical Practice.

[203]  J G Fletcher,et al.  Time interval between abnormalities seen on CT and the clinical diagnosis of pancreatic cancer: retrospective review of CT scans obtained before diagnosis. , 2004, AJR. American journal of roentgenology.

[204]  Alison P. Klein,et al.  Prospective Risk of Pancreatic Cancer in Familial Pancreatic Cancer Kindreds , 2004, Cancer Research.

[205]  C. Rosty,et al.  Molecular pathogenesis of pancreatic cancer. , 2002, Hematology/oncology clinics of North America.

[206]  M S Pepe,et al.  Phases of biomarker development for early detection of cancer. , 2001, Journal of the National Cancer Institute.

[207]  R H Hruban,et al.  Pancreatic Intraepithelial Neoplasia: A New Nomenclature and Classification System for Pancreatic Duct Lesions , 2001, The American journal of surgical pathology.

[208]  M. Kimmey,et al.  Early Diagnosis and Treatment of Pancreatic Dysplasia in Patients with a Family History of Pancreatic Cancer , 1999, Annals of Internal Medicine.

[209]  E. Gold,et al.  Epidemiology of and risk factors for pancreatic cancer. , 1995, The Surgical clinics of North America.

[210]  W. Steinberg The clinical utility of the CA 19-9 tumor-associated antigen. , 1990, The American journal of gastroenterology.

[211]  M. Gail,et al.  Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. , 1989, Journal of the National Cancer Institute.

[212]  J. Wolfe Breast patterns as an index of risk for developing breast cancer. , 1976, AJR. American journal of roentgenology.

[213]  K. Jenpanich,et al.  [Drug administration]. , 1976, Thai journal of nursing.

[214]  Marvin Minsky,et al.  Perceptrons: An Introduction to Computational Geometry , 1969 .